ZOCAGLUSAGENE NUZAPARVOVEC
UNII FDB4GQ8A3Y

Substance Identification & Data

This profile provides standardized clinical and technical data for Zocaglusagene Nuzaparvovec, uniquely identified by the FDA Unique Ingredient Identifier (UNII) FDB4GQ8A3Y.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2601264-52-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

FDB4GQ8A3Y

CAS Registry Number

2601264-52-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ZOCAGLUSAGENE NUZAPARVOVEC

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C190444

National Cancer Institute reference terminology for clinical and research data.

INN ID

12248

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

LM-146

Identifier assigned by the United States Adopted Names Council.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Zocaglusagene Nuzaparvovec. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ZOCAGLUSAGENE NUZAPARVOVEC

Common Names & Synonyms

AT845

DNA (RECOMBINANT ADENO-ASSOCIATED VIRUS VECTOR AT845 MOUSE MUSCLE-TYPE CREATINE KINASE ENHANCER PLUS MOUSE MUSCLE-TYPE CREATINE KINASE PROMOTER PLUS HUMAN LYSOSOMAL .ALPHA.-GLUCOSIDASE PRECURSOR CODON-OPTIMIZED TRANSGENE PLUS SIMIAN VIRUS 40 POLYADENYLATION SIGNAL PLUS ADENO-ASSOCIATED VIRUS 2 INVERTED TERMINAL REPEAT FLANKS-SPECIFYING)

RECOMBINANT, NON-REPLICATING ADENO-ASSOCIATED VIRUS SEROTYPE 8 (RAAV8) VECTOR ENCODING CODON-OPTIMIZED HUMAN ACID ALPHA-GLUCOSIDASE (GAA), ALSO CALLED LYSOSOMAL .ALPHA.-GLUCOSIDASE OR ACID MALTASE, UNDER CONTROL OF A MOUSE MUSCLE CREATINE KINASE (MCK) ENHANCER/PROMOTER FOLLOWED BY A SIMIAN VIRUS 40 (SV40) INTRON, TERMINATED BY THE SV40 LATE POLYADENYLATION SEQUENCE, AND FLANKED BY AAV2 INVERTED TERMINAL REPEATS (ITRS)

ZOCAGLUSAGENE NUZAPARVOVEC [INN]

ZOCAGLUSAGENE NUZAPARVOVEC [USAN]